Caberfix-0.5 Tablet

Cabergoline 0.5 mg Tablets — Long-Acting Dopamine D2 Agonist

Caberfix-0.5 Tablet — Cabergoline 0.5 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Cabergoline 0.5 mg
Dosage Form Tablet
Pack Type Blister
Pack Size 4 x 4 / 10 x 4 Tablets
MRP ₹ 3800
Therapy Gynaecology + Infertility — Long-Acting Dopamine D2 Agonist
Storage Store below 25 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Caberfix-0.5 Tablet

Caberfix-0.5 Tablet contains Cabergoline 0.5 mg, a selective long-acting D2 dopamine agonist used for the treatment of hyperprolactinaemia, prolactin-secreting pituitary adenomas (prolactinomas) and lactation suppression. Its long half-life (~65 hours) allows once or twice weekly dosing — a major adherence advantage over earlier dopamine agonists like Bromocriptine which require daily dosing.

By stimulating pituitary D2 receptors, Cabergoline inhibits prolactin secretion from lactotrophs, normalising serum prolactin levels and (in prolactinoma) shrinking tumour mass. It restores normal menstrual cycles in hyperprolactinaemic infertility, reduces galactorrhoea, and stops physiological lactation when used post-partum for medically indicated suppression.

Caberfix-0.5 is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a specialty gynaecology/endocrinology SKU.

Indications

  • Hyperprolactinaemia (idiopathic or drug-induced)
  • Prolactin-secreting pituitary adenomas (prolactinoma)
  • Hyperprolactinaemia-associated infertility and amenorrhoea
  • Galactorrhoea
  • Lactation suppression (medically indicated, post-partum)
  • Adjunct in some Parkinson's protocols (specialist use)

Mechanism of Action

Cabergoline is a long-acting ergot-derived D2 dopamine receptor agonist with high affinity for pituitary lactotroph D2 receptors. Agonist binding inhibits adenylate cyclase, lowers intracellular cAMP and suppresses prolactin gene transcription and secretion. The long half-life results in sustained prolactin suppression with weekly dosing.

Dosage & Administration

Hyperprolactinaemia: 0.25 mg twice weekly initially, titrated based on serum prolactin to 0.5–1 mg weekly. Prolactinoma: up to 4.5 mg weekly. Lactation suppression: single 1 mg dose within 24 hours of delivery. To be prescribed by an endocrinologist or gynaecologist.

Side Effects

Nausea, vomiting, headache, dizziness, postural hypotension, abdominal pain, fatigue. With long-term high-dose use (Parkinson's): cardiac valve regurgitation, retroperitoneal/pleural fibrosis (rare in gynaecological doses).

Contraindications & Precautions

Hypersensitivity to ergot alkaloids. Uncontrolled hypertension. History of cardiac valvulopathy or fibrotic disorders. Pregnancy-induced hypertension and pre-eclampsia. Severe hepatic impairment. Concurrent dopamine antagonists (antipsychotics, metoclopramide).

Storage

Store below 25 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Caberfix-0.5 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Caberfix-0.5 Tablet used for?

Caberfix-0.5 contains Cabergoline 0.5 mg and is used for hyperprolactinaemia, prolactinoma, prolactin-related infertility, galactorrhoea and post-partum lactation suppression.

How often is Caberfix-0.5 taken?

Once or twice a week — Cabergoline's long half-life (~65 hours) supports weekly or twice-weekly dosing, unlike older daily-dose dopamine agonists like Bromocriptine.

Is Caberfix-0.5 available for PCD pharma franchise?

Yes, Trumac Healthcare offers Caberfix-0.5 on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Caberfix-0.5 Tablet be stored?

Store below 25 °C in a dry place, protected from light and moisture.

Is Caberfix-0.5 WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.